These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 7890215)

  • 1. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
    Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
    Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: pathogenesis of gallstones.
    Dowling RH
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
    Hussaini SH; Pereira SP; Murphy GM; Dowling RH
    Hepatology; 1995 Dec; 22(6):1735-44. PubMed ID: 7489982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
    Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
    Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxycholic acid is not related to lithogenic factors in gallbladder bile.
    Jüngst D; Müller I; Kullak-Ublick GA; Meyer G; Frimberger E; Fischer S
    J Lab Clin Med; 1999 Apr; 133(4):370-7. PubMed ID: 10218768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.
    Makino I; Chijiiwa K; Higashijima H; Nakahara S; Kishinaka M; Kuroki S; Mibu R
    Gut; 1994 Dec; 35(12):1760-4. PubMed ID: 7829016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.
    Gustafsson U; Sahlin S; Einarsson C
    World J Gastroenterol; 2003 Jul; 9(7):1576-9. PubMed ID: 12854167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
    Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
    Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cholesterol-phospholipid vesicles and cholesterol crystals in human gallbladder bile.
    Schriever CE; Jüngst D
    Hepatology; 1989 Apr; 9(4):541-6. PubMed ID: 2925158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gall bladder bile and endoscopically obtained duodenal bile.
    Janowitz P; Swobodnik W; Wechsler JG; Zöller A; Kuhn K; Ditschuneit H
    Gut; 1990 Dec; 31(12):1407-10. PubMed ID: 2265783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.
    Marcus SN; Heaton KW
    Gut; 1986 May; 27(5):550-8. PubMed ID: 3699564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
    Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
    Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diurnal variation in cholesterol saturation of gall-bladder bile.
    Kupfer RM; Northfield TC
    Gut; 1983 Oct; 24(10):950-3. PubMed ID: 6684613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.